Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Defense
Manufacturing
WuXi AppTec wins temporary relief in DOD classification feud
Chief Judge James Boasberg said WuXi AppTec had made a reasonable case that the Defense Department acted in an “arbitrary and capricious” manner.
Fraiser Kansteiner
Aug 11, 2026 11:33am
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
Jun 9, 2026 12:24pm
WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
Dec 4, 2025 8:55am
Valneva nabs $33M US supply pact for Japanese encephalitis shot
Feb 3, 2025 11:32am
DOD enlists Evotec subsidiary in antibody manufacturing program
Jun 26, 2024 4:15am
WuXi AppTec refutes claim of secret IP transfer in letter to DOD
May 13, 2024 3:00pm
